Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.11.010

Related search